BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 19244126)

  • 1. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.
    Detta A; Cruickshank GS
    Cancer Res; 2009 Mar; 69(5):2126-32. PubMed ID: 19244126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
    Takagaki M; Ono K; Oda Y; Kikuchi H; Nemoto H; Iwamoto S; Cai J; Yamamoto Y
    Cancer Res; 1996 May; 56(9):2017-20. PubMed ID: 8616843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001).
    Wittig A; Sheu-Grabellus SY; Collette L; Moss R; Brualla L; Sauerwein W
    Appl Radiat Isot; 2011 Dec; 69(12):1807-12. PubMed ID: 21367608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca PL; Fand I; Joel DD
    Cancer Res; 1990 Jan; 50(1):138-41. PubMed ID: 2293547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
    Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Tjarks W; Lorey DR; Barth RF
    J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
    Papaspyrou M; Feinendegen LE; Müller-Gärtner HW
    Cancer Res; 1994 Dec; 54(24):6311-4. PubMed ID: 7987818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.